CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


<
Celgene Corp  (CELG)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 


 

Celgene Corp

CELG's Financial Statements and Analysis




Celgene Corp reported in II. Quarter net earnings per share of $1.31 an increase by 0 % year on year from $0.75 and an improvement of 0 % from $1.16 realized in I. Quarter (Mar 31 2017).

Celgene's Revenue rose by % in II. Quarter (Jun 30 2017) year on year, to $3,268 million and advanced by 10.41 % sequentially.


Celgene is Expected to report next financial results on October 23, 2017.
More on CELG's Income Statement

II. Quarter
Earnings Per Share Revenues
$ 1.31 $  3,268 Mill
$+0.56     +74.67 % $+514M     +18.65 %
You need to upgrade your Flash Player


       
  • REVLIMID 11.81% Y/Y,
• ABRAXANE 8.34% Y/Y,
• Other 350% Y/Y,
• Total product sales 18.18% Y/Y,
• ISTODAX 10.19% Y/Y,
• POMALYST, IMNOVID 41.63% Y/Y,
• azacitidine injection 7.04% Y/Y
   
     
       
  • THALOMID -13.1% Y/Y,
• VIDAZA -6.46% Y/Y
   
     


CELG's Segments

CELG's NET INCOME

Celgene's net income of $1,061 million in II. Quarter increased by 77.37 % from net earnings of $598 million achieved in II. Quarter a year ago.

Sequentially net earnings grew by 12.75 % from net income of $941.00 million realized in previous quarter.

More on CELG's Growth

Inventories Inventories grew by 8.69 % to $533 million from II. Quarter a year ago, sequentially inventories rose by 4.72 %. CELG's Cash flow In II. Quarter company's net cash flow was $1,387 million, capital expenditures fell by 60.18%, to $-70 millions compare to same quarter a year ago and fell by 12.90% from I. Quarter (Mar 31 2017).

More on CELG's Cash flow Statement



Celgene Corp does not pay out common stock dividend.

In trailing twelve-month period Celgene Corp earned $ 5.42 cash per share, on a free-cash flow basis 168.93 % of net earning per share.

Book value grew by 10.41 % sequentially to $10.40 per share, 108.29% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ -8.18 per share from $ -9.28.

Company issued 0.50 million shares or 0.06 % in II. Quarter.
Interest Coverage Ratio was 6.73. Debt Coverage Ratio was 0.24.

More on CELG's Dividends
 Market Capitalization (Millions) 106,544
 Shares Outstanding (Millions) 812
 Total Debt (Millions $) 14,283
 Revenue (TTM) (Millions $) 12,191
 Net Income (TTM) (Millions $) 2,602
 Cash Flow (TTM) (Millions $) 1,596
 Capital Exp. (TTM) (Millions $) -265
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 6,012


   

Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
SSC's Profile
Stock Price
SSC's Financials
SSC's Expectations
Business Description
Fundamentals
Charts & Quotes
SSC's News
Suppliers
SSC's Competitors
Customers & Markets
Economic Indicators
SSC's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com